Abstract:The use of high-field magnets for magnetic resonance imaging (MRI) is expected to experience the fastest growth rate during the present decade. Although several CAs for MRI scanners using high magnetic fields have been reported, they are mostly based on fluoride matrices, which are known for their low chemical stability in aqueous suspensions. Chemically stable MRI CAs for high-field magnets are therefore needed to enable the advances in MRI technique. Herein, we synthesized uniform DyPO4 nanoparticles (NPs) with tuneable sizes between 23 and 57 nm using homogeneous precipitation in butanol. The NPs were successfully functionalized with polyacrylic acid (PAA) and showed good colloidal stability in aqueous suspensions. Chemical stability was also assessed in PBS, showing negligible solubility. The effect of particle size on the transversal relaxivity value (r2) was further explored at 9.4 T, finding a clear increase in r2 with particle size. The r2 value found for the largest NPs was 516 mM-1 s-1, which is, to the best of our knowledge, the highest r2 value ever reported at 9.4 T for any Dy-based nanometric particles in the literature. Finally, the latter NPs were submitted to biosafety studies after polyethylene glycol (PEG) functionalization. Cell morphology, induction of necrotic/late apoptotic cells, and mitochondrial activity were thoroughly analyzed. The results clearly indicated negligible toxicity effects under the assayed conditions. Short- and long-term in vivo pharmacokinetics of the intravenously injected NPs were assessed by dynamic T2-weighted MRI and quantitative T2 mapping, revealing faster liver than spleen uptake, while no accumulation was observed in the kidneys. Finally, no histopathological changes were observed in any of the studied organs, including the liver, kidney, spleen, and lung, which provide further evidence of the biocompatibility of DyPO4 NPs and, therefore, their suitability as bioimaging probes.

Water‐Soluble Spinel Ferrites by a Modified Polyol Process as Contrast Agents in MRI

Polyol Synthesis of Superparamagnetic Fe_3O_4 Nanoparticles for Magnetic Resonance Imaging

Solid-state Synthesis of Monocrystalline Iron Oxide Nanoparticle Based Ferrofluid Suitable for Magnetic Resonance Imaging Contrast Application

Synthesis of Well-Dispersed Aqueous-Phase Magnetite Nanoparticles and Their Metabolism As an Mri Contrast Agent for the Reticuloendothelial System

Development of Polymer-Encapsulated, Amine-Functionalized Zinc Ferrite Nanoparticles as MRI Contrast Agents

Synthesis and characterization of stable water-soluble Fe3O4 nanoparticles

Synthesis of sub-100 nm biocompatible superparamagnetic Fe3O4 colloidal nanocrystal clusters as contrast agents for magnetic resonance imaging

Synthesis, Characterization, and In Vitro Study of Dextrin-Coated Bismuth-Doped Manganese Ferrite Nanoparticles (Bio.3Mno.55Fe2O4) as an MRI Contrast Agent

Microwave-Assisted Synthesis of Magnetite Nanoparticles for Mr Blood Pool Contrast Agents

Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent.

Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.

Fe3O4 Nanoparticles Functionalized with Polymer Ligand for T-1-Weighted MRI in Vitro and in Vivo

2, 3-Dimercaptosuccinic Acid-Modified Iron Oxide Clusters for Magnetic Resonance Imaging

Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast<i>T</i><sub>1</sub>- and<i>T</i><sub>2</sub>-weighted magnetic resonance imaging

Fe3+@polyDOPA-b-polysarcosine, a T1-Weighted MRI Contrast Agent Via Controlled NTA Polymerization.

Synthesis of Surface Modified Fe3O4 Super Paramagnetic Nanoparticles for Ultra Sound Examination and Magnetic Resonance Imaging for Cancer Treatment.

Outstanding MRI contrast with dysprosium phosphate nanoparticles of tuneable size

[Behavioral and neurochemical changes in pups prenatally treated with methamphetamine].

Continuous Synthesis of Extremely Small-Sized Iron Oxide Nanoparticles Used for T1-weighted Magnetic Resonance Imaging Via a Fluidic Reactor

Synthesis and characterization of PEG-coated Zn$_{0.3}$Mn$_x$Fe$_{2.7-x}$O$_4$ nanoparticles as the dual T1/T2-weighted MRI contrast agent

A Multifunctional Contrast Agent for 19 F-Based Magnetic Resonance Imaging